Abstract
It has been shown experimentally that the drug amino-oxyacetic acid (AOA) can raise the level of gamma aminobutyric acid (GABA) in the brain. Since GABA is a powerful neuronal inhibitor it seemed worth while to assess the value of AOA as an anticonvulsant.
This drug was given to 23 infants and children, all but one of whom were resistant to usual anticonvulsant medication. The types of seizure patterns were classed as major (including focal) and minor (akinetic, myoclonic and hypsarrhythmic) and the patients were followed for up to one year. Of eight children with major seizures, five were improved; of eight with minor seizures, three were improved; and of six with hypsarrhythmia, none were improved. One patient with phenylketonuria and minor seizures was improved.
It is concluded that this approach to anticonvulsant therapy is worth pursuing and that the drug may also find some use in the treatment of phenylketonuria and of seizures due to vitamin B6 dependency.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ELLIOTT K. A., JASPER H. H. Gammaaminobutyric acid. Physiol Rev. 1959 Apr;39(2):383–406. doi: 10.1152/physrev.1959.39.2.383. [DOI] [PubMed] [Google Scholar]
- MARRAZZI A. S., HART E. R., RODRIGUEZ J. M. Action of blood-borne gamma-aminobutyric acid on central synapses. Science. 1958 Feb 7;127(3293):284–285. doi: 10.1126/science.127.3293.284. [DOI] [PubMed] [Google Scholar]
- TASHIAN R. E. Inhibition of brain glutamic acid decarboxylase by phenylalanine, valine, and leucine derivatives: a suggestion concerning the etiology of the neurological defect in phenylketonuria and branched-chain ketonuria. Metabolism. 1961 May;10:393–402. [PubMed] [Google Scholar]